Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold R Collard

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
Scientific Reports|January 23, 2016
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease ProbesNimali P Withana, Xiaowei Ma, Helen M McGuire, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
Annals of Internal Medicine|May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialGanesh Raghu, Juergen Behr, Kevin K Brown, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
Scientific Reports|January 23, 2016
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease ProbesNimali P Withana, Xiaowei Ma, Helen M McGuire, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
The Lancet. Respiratory Medicine|December 13, 2016
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trialGanesh Raghu, Kevin K Brown, Harold R Collard, et al.
Annals of Internal Medicine|May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialGanesh Raghu, Juergen Behr, Kevin K Brown, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
Pageof 22